July 27, 2022 New York, when Lupus Research Alliance shared that GSK's Benlysta or belimumab is now US FDA Approved as the first-ever treatment that specifically treats children and teenager battling lupus and lupus nephritis. This is specifically indicated for children aged 5 to 17 with lupus nephritis.
Lupus Nephritis in Children
About 8 out of 10 pediatric lupus patients can develop kidney damage resulting from Lupus Nephritis. When the kidneys become inflamed and damaged, they can't effectively eliminate waste and toxins in the body that can lead to End Stage Renal Disease.
Benlysta or belimumab is a much-needed treatment for pediatric patients battling lupus nephritis. This could be another much-awaited medicine for the pediatric lupus community in the Philippines too.
To read furthermore about this great news, visit the link below:
Do you have a child battling Lupus, what can you say about this first-ever specific treatment for pediatric lupus patients?
Σχόλια